Medical specialists from France tagged as investigators in clinical trials studying Polycystic Kidney, Autosomal Dominant

Total 29 results

Angelo Testa, MD
Seen in:
- Reze, ECHO Confluent
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Antoine Durrbach, MD
Seen in:
- Le Kremlin-Bicêtre, Hospital Henri-Mondor AP-HP
Trials:
- NCT03918447 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney;
- ADPKD
Antoine Thierry, MD PhD
Seen in:
- Poitiers, CHU Poitiers
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Bassem Wehbe, MD
Seen in:
- Quimper, CHI de Cournouaille
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Bertrand Knebelmann, MD
Seen in:
- Paris, Hopital Necker, Universite Paris Descartes
Trials:
- NCT03749447 (Principal Investigator)
- NCT03918447 (Principal Investigator)
Conditions:
Christophe Charasse, MD
Seen in:
- Saint Brieuc, CH Yves Le Foll
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Corneliu Savoiu, MD
Seen in:
- Saint Herblain, ECHO Centre Ambulatoire
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Didier Legrand, MD
Seen in:
- Lorient, AUB Lorient
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Dominique Besnier, MD
Seen in:
- Saint Nazaire, CH de Saint Nazaire
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Dominique Chaveau, Prof
Seen in:
- Toulouse, Hôpital de Rangueil
Trials:
- NCT02187432 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Eric Renaudineau, MD
Seen in:
- Saint Malo, CH Saint Malo
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Guillaume Seret, MD
Seen in:
- Le Mans, ECHO dialyse
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Jean Francois Augusto, MD PhD
Seen in:
- Angers, CHU Angers
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Jean Paul Jaulin, MD
Seen in:
- La Roche sur Yon, CH La Roche sur Yon
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Jean Philippe Coindre, MD
Seen in:
- Le Mans, CH Le Mans
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Katell Goulesque, MD
Seen in:
- Brest, Centre Nephrologie et Dialyse d Armorique
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Lucile Figueres, MD
Seen in:
- Nantes, CHU de Nantes
Trials:
- NCT03918447 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney;
- ADPKD
Marin Le Mee, MD
Seen in:
- Morlaix, AUB Morlaix
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Maryvonne Hourmand, MD PhD
Seen in:
- Nantes, CHU Nantes
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Mathias Buchler, MD PhD
Seen in:
- Tours, CHU Tours
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Philippe Jousset, MD
Seen in:
- Pontivy, CH Centre Bretagne
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Philippe Zaoui, MD
Seen in:
- Grenoble, Chu Grenoble Alpes
Trials:
- NCT03749447 (Principal Investigator)
- NCT03918447 (Principal Investigator)
Conditions:
Regine Perrichot, MD
Seen in:
- Vannes, CH Bretagne Atlantique
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Seddik Benarbia, MD
Seen in:
- Quimper, AUB Quimper
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Sonia Mzoughi, MD
Seen in:
- Roscoff, Centre Heliomarin de Roscoff
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Theophile Sawadogo, MD
Seen in:
- Lorient, CH Bretagne Sud
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Victorio Menoyo, MD
Seen in:
- Vannes, ECHO Vannes
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Yannick Le Meur, Prof
Seen in:
- Brest, Centre Hospitalier Universitaire de Brest
Trials:
- NCT02187432 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Yannick LeMeur, MD
Seen in:
- Brest, University Hospital La Cavale Blanche
Trials:
- NCT03918447 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney;
- ADPKD

Clinical Trials on Polycystic Kidney, Autosomal Dominant

Emory University
PKD Foundation

Completed

ADPKD Cohort Study

Autosomal Dominant Polycystic Kidney Disease

United States
Mario Negri Institute for Pharmacological Research
Otsuka Pharmaceutical Italy S.r.l.

Completed

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

Autosomal Dominant Polycystic Kidney Disease

Italy
CHU de Reims

Completed

ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure? (PDP-ADPKD)

Autosomal Dominant Polycystic Kidney Disease

France
Otsuka Pharmaceutical Development & Commercialization...

Completed

Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD

Autosomal Dominant Polycystic Kidney Disease

United States
Regional Hospital Holstebro
Aarhus University Hospital

Completed

Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TOPO)

Autosomal Dominant Polycystic Kidney Disease

Denmark
University Hospital, Brest

Unknown

Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease) (GENKYST)

Autosomal Dominant Polycystic Kidney Disease

France
Federico II University

Completed

Effects of Somatostatin on Liver in ADPKD

Autosomal Dominant Polycystic Kidney Disease
Kadmon Corporation, LLC

Terminated

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States
Kyorin University

Unknown

Efficacy of Tolvaptan on ADPKD Patients

Autosomal Dominant Polycystic Kidney Disease

Japan
University of North Carolina, Chapel Hill
National Institute of General Medical Sciences (NIGMS)

Completed

ADPKD Alterations in Hepatic Transporter Function

Renal Disease | Autosomal Dominant Polycystic Kidney Disease | ADPKD

United States

Medical specialists from France tagged as investigators in clinical trials studying Polycystic Kidney, Autosomal Dominant

Clinical Trials on Polycystic Kidney, Autosomal Dominant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations